NO910608D0 - Fremgangsmaate for fremstilling av tricykliske leukotrien-antagonister. - Google Patents

Fremgangsmaate for fremstilling av tricykliske leukotrien-antagonister.

Info

Publication number
NO910608D0
NO910608D0 NO910608A NO910608A NO910608D0 NO 910608 D0 NO910608 D0 NO 910608D0 NO 910608 A NO910608 A NO 910608A NO 910608 A NO910608 A NO 910608A NO 910608 D0 NO910608 D0 NO 910608D0
Authority
NO
Norway
Prior art keywords
tricyclic
procedure
manufacture
leukotrien
antagonists
Prior art date
Application number
NO910608A
Other languages
English (en)
Other versions
NO910608L (no
NO177097C (no
NO177097B (no
Inventor
Darrel Mark Gapinski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO910608D0 publication Critical patent/NO910608D0/no
Publication of NO910608L publication Critical patent/NO910608L/no
Publication of NO177097B publication Critical patent/NO177097B/no
Publication of NO177097C publication Critical patent/NO177097C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/88Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO910608A 1990-02-16 1991-02-15 Analogifremgangsmåte for fremstilling av tricykliske leukotrien-antagonister NO177097C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/481,413 US4996230A (en) 1990-02-16 1990-02-16 Leukotriene antagonists

Publications (4)

Publication Number Publication Date
NO910608D0 true NO910608D0 (no) 1991-02-15
NO910608L NO910608L (no) 1991-08-19
NO177097B NO177097B (no) 1995-04-10
NO177097C NO177097C (no) 1995-07-19

Family

ID=23911845

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910608A NO177097C (no) 1990-02-16 1991-02-15 Analogifremgangsmåte for fremstilling av tricykliske leukotrien-antagonister

Country Status (20)

Country Link
US (1) US4996230A (no)
EP (1) EP0442748B1 (no)
JP (1) JPH04211037A (no)
KR (1) KR910015558A (no)
CN (1) CN1028639C (no)
AR (1) AR247205A1 (no)
AT (1) ATE116980T1 (no)
AU (1) AU631482B2 (no)
CA (1) CA2036523A1 (no)
DE (1) DE69106545T2 (no)
FI (1) FI910728A (no)
HU (1) HU208431B (no)
IE (1) IE910531A1 (no)
IL (1) IL97242A0 (no)
NO (1) NO177097C (no)
NZ (1) NZ237124A (no)
PT (1) PT96760A (no)
RU (1) RU2007401C1 (no)
YU (1) YU27691A (no)
ZA (1) ZA911111B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30449A (en) * 1991-11-25 1997-05-28 Lilly Co Eli Substituted phenyl phenol leukotriene antagonists
US5352690A (en) * 1992-07-01 1994-10-04 Eli Lilly And Company 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists
CN1110875A (zh) * 1993-06-18 1995-10-25 大塚制药株式会社 芴酮衍生物,其制备方法及中枢或外周神经退化修复与保护剂
CN1166834A (zh) * 1994-10-13 1997-12-03 美国辉瑞有限公司 苯并吡喃和苯并稠合化合物,其制备方法和它们作为白三烯b4(ltb4)拮抗剂的用途
CZ111797A3 (cs) * 1994-10-13 1998-07-15 Pfizer Inc. Benzopyranové a jiné sloučeniny s přikondenzovaným benzenovým kruhem a farmaceutické prostředky na jejich bázi
US5977077A (en) * 1995-08-28 1999-11-02 Interlab Corporation Xanthone analogs for the treatment of infectious diseases
CA2199104A1 (en) 1996-03-05 1997-09-05 Tsuneaki Hida Xanthene derivatives, their production and use
WO2001041773A1 (en) 1999-12-02 2001-06-14 Interlab, Inc. Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins
US20080293750A1 (en) * 2002-10-17 2008-11-27 Anna Helgadottir Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
US8158362B2 (en) * 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
US20100216863A1 (en) * 2004-01-30 2010-08-26 Decode Genetics Ehf. Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
CN112285355B (zh) * 2020-10-20 2023-01-13 四川大学华西医院 Viridiflorin检测试剂在制备COPD诊断试剂盒中的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7008627A (no) * 1969-06-25 1970-12-29
US3987088A (en) * 1971-09-08 1976-10-19 Burroughs Wellcome Co. Cyclic carbonyl compounds
FR2278331A1 (fr) * 1974-01-24 1976-02-13 Roussel Uclaf Nouveaux acides carboxyliques et leurs derives, leur application comme medicaments et leur procede de preparation
US4166819A (en) * 1975-09-24 1979-09-04 Abbott Laboratories 4-Aroyl substituted phenoxy methylene-5-tetrazoles
GB1543964A (en) * 1976-04-08 1979-04-11 Ici Ltd Method of antagonising herbicides on soyabean and cotton
GR78142B (no) * 1982-04-27 1984-09-26 Wellcome Found
SE8400239D0 (sv) * 1984-01-19 1984-01-19 Pharmacia Ab Nya arylettiksyraderivat
US4661607A (en) * 1984-09-21 1987-04-28 Chugai Seiyaku Kabushiki Kaisha Furoxanthone derivatives useful as diuretics
JP2672101B2 (ja) * 1986-12-23 1997-11-05 ディーエフシー ニュージーランド リミテッド キサンテノン−4−酢酸誘導体
CA1320490C (en) * 1987-01-12 1993-07-20 Darrel M. Gapinski Anti-inflammatory agents
US5242121A (en) * 1991-08-23 1993-09-07 Roto-Mix Enterprises, Ltd. Bale support and cutter

Also Published As

Publication number Publication date
RU2007401C1 (ru) 1994-02-15
HU208431B (en) 1993-10-28
DE69106545D1 (de) 1995-02-23
NO910608L (no) 1991-08-19
KR910015558A (ko) 1991-09-30
IE910531A1 (en) 1991-08-28
EP0442748B1 (en) 1995-01-11
CN1028639C (zh) 1995-05-31
AR247205A1 (es) 1994-11-30
CN1054066A (zh) 1991-08-28
AU7110391A (en) 1991-08-22
NO177097C (no) 1995-07-19
HUT56359A (en) 1991-08-28
PT96760A (pt) 1991-11-29
NO177097B (no) 1995-04-10
US4996230A (en) 1991-02-26
DE69106545T2 (de) 1995-06-01
JPH04211037A (ja) 1992-08-03
IL97242A0 (en) 1992-05-25
EP0442748A1 (en) 1991-08-21
YU27691A (sh) 1994-04-05
ZA911111B (en) 1992-10-28
AU631482B2 (en) 1992-11-26
FI910728A (fi) 1991-08-17
NZ237124A (en) 1992-04-28
CA2036523A1 (en) 1991-08-17
FI910728A0 (fi) 1991-02-14
ATE116980T1 (de) 1995-01-15

Similar Documents

Publication Publication Date Title
NO905255L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte acylaminotiazoler.
NO912848D0 (no) Substituerte azoler, fremgangsmaate for fremstilling deravog anvendelse av forbindelsene.
NO912051D0 (no) Fremgangsmaate for fremstilling av azolderivater.
NO874959L (no) Fremgangsmaate for fremstilling av tricykliske ketoner.
NO912411D0 (no) Fremgangsmaate for fremstilling av bicykliske heterocykliske forbindelser.
NO904453L (no) Fremgangsmaate for fremstilling av bituminoese materialer.
NO912346L (no) Fremgangsmaate for fremstilling av aminobenzodiazepiner.
NO902003L (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO911122D0 (no) Fremgangsmaate for fremstilling av antihyperkolesterolemiske midler.
NO910608D0 (no) Fremgangsmaate for fremstilling av tricykliske leukotrien-antagonister.
NO901554D0 (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO904285D0 (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO910473D0 (no) Fremgangsmaate for fremstilling av tricykliske aminer.
NO890483D0 (no) Framgangsmaate for tilvirkning av formlegemer.
NO913391D0 (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
FI904676A0 (fi) Anordning foer loesgoerande av manteln i en haeftapparat.
FI900688A0 (fi) Anordning foer luftning av liggunderlag i sjuksaeng.
NO913360L (no) Fremgangsmaate for fremstilling av syntesegass.
NO913692D0 (no) Fremgangsmaate for fremstilling av karbapenemforbindelser.
NO911118D0 (no) Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner.
NO901067L (no) Fremgangsmaate for fremstilling av tiofener.
NO904060D0 (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO900381D0 (no) Fremgangsmaate for fremstilling av nafthalenderivater.
NO912673L (no) Fremgangsmaate for fremstilling av 7-amino-4,6-dinitrobenzofuroksan.